GLP-1 therapy associated with hair loss in people with type 2 diabetes

GLP-1 receptor agonist therapy was associated with an increased risk for hair loss among adults with type 2 diabetes compared with other commonly used diabetes drugs, according to a study published in The BMJ. The risk, which was specific to nonscarring alopecia, was greater among people receiving GLP-1 treatment vs. sodium-glucose cotransporter-2 (SGLT-2) inhibitors and dipeptidyl peptidase-4